|
⚲
|
| Keyboard |
| Abdul-Ahad Wajdi
✚
|
|
|---|---|
| CIK # | 0001812749 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001812749] | |
| 4 | [0001812749] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Abdul-Ahad Wajdi | |
| Ritter Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
|
2022-07-11 | Grant | 80,000 | $0.00 | |
|
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
|
2020-06-06 | Grant | 500,000 | $0.00 | |
|
Ritter Pharmaceuticals Inc QLGN
Warrant (Right to Buy) · derivative
|
2020-05-22 | Other | 7,971 | ||
|
Ritter Pharmaceuticals Inc QLGN
Warrant (Right to Buy) · derivative
|
2020-05-22 | Other | 8,857 |